Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement

Launched by DEUTSCHES HERZZENTRUM MUENCHEN · Feb 6, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how to best manage pacemaker implantation in patients who have undergone a procedure called transcatheter tricuspid valve replacement (TTVR). TTVR is used to treat conditions like tricuspid regurgitation, where the heart's tricuspid valve doesn’t close properly, and it can sometimes lead to a serious heart rhythm problem called third-degree atrioventricular block (AVB). The researchers want to find the best way to handle the need for a pacemaker, which is a device that helps regulate the heart’s rhythm, after this valve replacement surgery.

If you're interested in participating in this trial, you might be eligible if you are scheduled to have TTVR. There are no specific exclusions listed, which means most people who meet the inclusion criteria can potentially join. Participants can expect to be part of a study that aims to improve care for patients like themselves, helping to determine the best approach for pacemaker use after this heart procedure. The trial is currently recruiting participants of all ages and genders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Transcatheter Tricuspid Valve Replacement
• Exclusion Criteria:
• • no defined exclusion criteria